Back to Search
DIANE JELINEK, PHD
PHD
Student in an Organized Health Care Education/Training Program
NPI: 1104968874Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training ProgramPrimary
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Human B lymphocyte malignancies: exploitation of BLyS and APRIL and their receptors.
PMID 15564725·Curr Dir Autoimmun·2005
6-review
Identification of a global gene expression signature of B-chronic lymphocytic leukemia.
PMID 12651908·Mol Cancer Res·2003
8-other
Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia.
PMID 11843819·Br J Haematol·2001
8-other
Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.
PMID 19470922·J Clin Oncol·2009
3-trial
Amelioration of enteric neuropathology in a mouse model of Niemann-Pick C by Npc1 expression in enteric glia.
PMID 19472223·J Neurosci Res·2009
7-preclinical
Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
PMID 19620484·J Clin Oncol·2009
4-observational
Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab.
PMID 19008456·Blood·2009
3-trial
B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome.
PMID 19015397·Blood·2009
8-other
Validation of a new prognostic index for patients with chronic lymphocytic leukemia.
PMID 19090008·Cancer·2009
4-observational
Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.
PMID 19255329·J Clin Oncol·2009
8-other
Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation.
PMID 19282458·Blood·2009
7-preclinical
Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.
PMID 18064298·J Clin Invest·2008
8-other
Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
PMID 18759253·Cancer·2008
3-trial
MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?
PMID 18179821·Leuk Res·2008
8-other
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
PMID 18373706·Br J Haematol·2008
8-other
B lymphocyte stimulator regulates adaptive immune responses by directly promoting dendritic cell maturation.
PMID 18490739·J Immunol·2008
8-other
Alternative splicing regulates activation-induced cytidine deaminase (AID): implications for suppression of AID mutagenic activity in normal and malignant B cells.
PMID 18684869·Blood·2008
7-preclinical
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.
PMID 18584865·Leuk Res·2008
3-trial
The Niemann-Pick C1 gene is downregulated by feedback inhibition of the SREBP pathway in human fibroblasts.
PMID 18272927·J Lipid Res·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 1ST ST SW
ROCHESTER, MN 55905 - Phone
- (507) 284-2511
Quick Facts
- NPI
- 1104968874
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile